A10 & AS2-1 Antineoplaston is designated as an orphan drug by the US FDA on 9/3/2004, used in treatment for patients with brain stem glioma, manufactured / distributed by Burzynski Research Institute, Inc.
This WikiMD article A10 & AS2-1 Antineoplaston is a stub. If you are familiar with the topic A10 & AS2-1 Antineoplaston, you can help us. Paid editors welcome!
A10 & AS2-1 Antineoplaston is part of WikiMD's free ^articles!
^A10 & AS2-1 Antineoplaston (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.